pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

Purdue Pharma LP

updated 2mo ago

Purdue Pharma L.P., formerly the Purdue Frederick Company (1892–2019), was an American privately held pharmaceutical company founded by John Purdue Gray. It was sold to Arthur, Mortimer, and Raymond Sackler in 1952, and then owned principally by the Sackler family and their descendants.

community read0 votes

🐶 often sniffed alongside

top 8
  • tagApproval202 co-mentions · 101 sources
  • drugMS CONTIN80 co-mentions · 40 sources
  • tagSmall Molecule75 co-mentions · 75 sources
  • drugOXYCODONE HYDROCHLORIDE70 co-mentions · 35 sources
  • drugOXYCONTIN70 co-mentions · 35 sources
  • drugBUTRANS52 co-mentions · 26 sources
  • drugSUBLOCADE52 co-mentions · 26 sources
  • drugKapanol40 co-mentions · 40 sources
pipeline
6
marketed
3
phase 3
0
catalysts ytd
1
approvals ytd
1
recalls ytd
0

Pipeline(6)

pipeline depth6 products
Marketed: 3Unknown: 3
3Marketed3Unknown
Marketed
BUTRANS
Marketed
Zurnai
Acute Opioid Overdosage
Marketed
hydrocodone bitartrate ER
Pain
drug
MS CONTIN
drug
NALMEFENE HYDROCHLORIDE
drug
OXYCONTIN

📅 Upcoming

no upcoming catalysts on record

🕒 Recent(90d)

nothing in the last 90 days
view all catalysts →

Active trials

  • phase1Pharmacokinetic (PK) Evaluation of Nalmefene Formulationscompletedn=13
  • phase1Pharmacodynamic Evaluation of Intramuscular Nalmefene Autoinjector 1.5 mg Compared to Intranasal Narcan 4 mgcompletedn=24
  • —Effect of Wearable Health Technology on Patients Treated for Chronic Pain at Geisinger Health Systemcompletedn=420
  • phase4Safety and Tolerability Study of Adhansia XR® Extended-Release Capsules in Childrenterminatedn=103
  • phase4Real-World Evidence of Duration of Effect of Adhansia XR (Extended-Release) for Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD)terminatedn=267
  • phase4Clinical Outcomes From Nalmefenewithdrawn
🐶 Hiring Signal
No open roles indexed yet — view Purdue Pharma LP jobs →

News

no news has mentioned this company yet
identifiers
source
globaldata
top tags
Dermatology1Major Depression1Pain1Pulmonology1
mentioned in
0news items
entity-linker matched
Data sources
openFDA
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?